The University of Buffalo (UB) Buffalo Translational Consortium has received nearly $22 million in grant money from the National Institutes of Health. UB’s translational consortium, a regional hub of innovative biomedical research, now receives funding to help it continue its important research focusing on key issues such as regional health disparities, social and medical determinants of health and correlations to deadly disease such as cancer.
What is UB’s Translational Research Consortium?
UB’s Clinical and Translational Research Center, the epicenter of this dynamic group, is part of the Jacobs School of Medicine and Biomedical Sciences (on the Buffalo Niagara Medical Campus). This hub includes five UB health sciences schools: Roswell Park Comprehensive Cancer Center, UBMD, Kaleida Health, Erie County Medical Center, and Buffalo VA Medical Center in addition to five UB research institutes and five additional community partners.
The Grant & Context
This grant represents a $21.7 million Clinical and Translational Science Award (CTSA) allocation from the National Center for Advancing Translational Sciences—part of the NIH. Other participants of this award include J...
Note: If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).